Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice

Neuroscience

Volumn 143, Issue 1, 2006, Pages 223-230

  Nemeth J ^a,b   ReglOdi D ^a   Pozsgai, G ^a   Szabo A ^a   Elekes, K ^a   Pinter E ^a   Szolcsanyi J ^a,b   Helyes, Z ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

calcitonin gene related peptides; capsaicin sensitive sensory nerves; isolated trachea; mustard oil; somatostatin; substance P

Indexed keywords

ALLYL ISOTHIOCYANATE; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE; SOMATOSTATIN; SUBSTANCE P;

ANGIONEUROTIC EDEMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC FIELD; ELECTROSTIMULATION; EVOKED RESPONSE; MALE; MOUSE; NEUROGENIC INFLAMMATION; NONHUMAN; OTITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SENSORY NERVE; SKIN EDEMA; SKIN INFLAMMATION; TRACHEA;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; EAR; ELECTRIC STIMULATION; HINDLIMB; MALE; MICE; MICE, INBRED BALB C; MUSTARD PLANT; NEUROGENIC INFLAMMATION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PLANT OILS; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SOMATOSTATIN; SUBSTANCE P;

EID: 33751062608     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.07.028     Document Type: Article

References (56)

1. Abad C., Gomariz R.P., and Waschek J.A. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr Top Med Chem 6 (2006) 151-163
2. Abad C., Martinez C., Leceta J., Gomariz R.P., and Delgado M. Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy. J Immunol 167 (2001) 3182-3189
3. Banvolgyi A., Pozsgai G., Brain S.D., Helyes Z.S., Szolcsányi J., Ghosh M., Melegh B., and Pintér E. Mustard oil induces a TRPV1 receptor independent neurogenic inflammation and a non-neurogenic cellular inflammatory component. Neuroscience 125 (2004) 449-459
4. Cardell L.O., Hjert O., and Uddman R. The induction of nitric oxide-mediated relaxation of human isolated pulmonary arteries by PACAP. Br J Pharmacol 120 (1997) 1096-1100
5. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
6. Fahrenkrug J., and Hannibal J. PACAP in visceral afferent nerves supplying the rat digestive and urinary tracts. Ann N Y Acad Sci 865 (1998) 542-546
7. Foda H.D., Sharaf H.H., Absood A., and Said S.I. Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity. Peptides 16 (1995) 1057-1061
8. Gamse R., Leeman S.E., Holzer P., and Lembeck F. Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol 317 (1981) 140-148
9. Ganea D., and Delgado M. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity. Crit Rev Oral Biol Med 13 (2002) 229-237
10. Geppetti P., and Holzer P. Neurogenic inflammation (1996), CRC Press Inc, Boca Raton
11. Hannibal J., and Fahrenkrug J. Pituitary adenylate cyclase-activating polypeptide in intrinsic and extrinsic nerves of the rat pancreas. Cell Tissue Res 299 (2000) 59-70
12. Helyes Z., Nemeth J., Pinter E., and Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol 121 (1997) 613-615
13. Helyes Z., Pinter E., Nemeth J., Keri G., Than M., Oroszi G., Horvath A., and Szolcsanyi J. Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br J Pharmacol 134 (2001) 1571-1579
14. Helyes Z., Pinter E., Nemeth J., and Szolcsanyi J. Pharmacological targets for the inhibition of neurogenic inflammation. Curr Med Chem 2 (2003) 191-218
15. Helyes Z., Szabo A., Nemeth J., Jakab B., Pinter E., Banvolgyi A., Kereskai L., Keri G., and Szolcsanyi J. Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat. Arthritis Rheum 50 (2004) 1677-1685
16. Hökfelt T., Elde R., Johansson O., Luft R., Nilsson G., and Arimura A. Immunohistochemical evidence for separate populations of somatostatin containing and substance P-containing primary afferent neurons in the rat. Neuroscience 1 (1976) 131-136
17. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24 (1988) 739-768
18. Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121 (1992) 49-146
19. Horvath P., Szilvassy J., Nemeth J., Peitl B., Szilasi M., and Szilvassy Z. Decreased sensory neuropeptide release in isolated bronchi of rats with cisplatin-induced neuropathy. Eur J Pharmacol 507 (2005) 247-252
20. Ichikawa H., and Sugimoto T. Pituitary adenylate cyclase-activating polypeptide-immunoreactive nerve fibers in rat and human tooth pulps. Brain Res 980 (2003) 288-292
21. Inoue H., Asaka T., Nagata N., and Koshihara Y. Mechanism of mustard oil-induced skin inflammation in mice. Eur J Pharmacol 333 (1997) 231-240
22. Jakab B., Reglodi D., Jozsa R., Hollosy T., Tamas A., Lubics A., Lengvari I., Oroszi G., Szilvassy Z., Szolcsanyi J., and Nemeth J. Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay. J Biochem Biophys Methods 61 (2004) 189-198
23. Jancso N., Jancso-Gabor A., and Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31 (1967) 138-151
24. Jancso-Gabor A., and Szolcsanyi J. Action of rare earth metal complexes on neurogenic as well as on bradykinin-induced inflammation. J Pharm Pharmacol 22 (1970) 366-371
25. Jordt S.E., Bautista D.M., Chuang H.H., McKemy D.D., Zygmunt P.M., Hogestatt E.D., Meng I.D., and Julius D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427 (2004) 260-265
26. Kato H., Ito A., Kawanokuchi J., Jin S., Mizuno T., Ojika K., Ueda R., and Suzumura A. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. Mult Scler 10 (2004) 651-659
27. Khawaja A.M., Liu Y.C., and Rogers D.F. Effect of fenspiride, a non-steroidal antiinflammatory agent, on neurogenic mucus secretion in ferret trachea in vitro. Pulm Pharmacol Ther 12 (1999) 363-368
28. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 45 (1995) 1-98
29. Mirabella N., Squillacioti C., Germano G., Varricchio E., and Paino G. Pituitary adenylate cyclase activating peptide (PACAP) immunoreactivity in the ureter of the duck. Cell Tissue Res 305 (2001) 341-349
30. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., and Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164 (1989) 567-574
31. Moller K., Zhang Y.Z., Hakanson R., Luts A., Sjolund B., Uddman R., and Sundler F. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience 57 (1993) 725-732
32. Moller M., Fahrenkrug J., and Hannibal J. Innervation of the rat pineal gland by pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive nerve fibres. Cell Tissue Res 296 (1999) 247-257
33. Mulder H., Uddman R., Moller K., Zhang Y.Z., Ekblad E., Alumets J., and Sundler F. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 63 (1994) 307-312
34. Nemeth J., Helyes Z., Gorcs T., Gardi J., Pinter E., and Szolcsanyi J. Development of somatostatin radioimmunoassay for the measurement of plasma and tissue contents of hormone. Acta Physiol Hung 84 (1996) 313-315
35. Nemeth J., Gorcs T., Helyes Z., Oroszi G., Kocsy T., Pinter E., and Szolcsanyi J. Development of a new sensitive CGRP radioimmunoassay for neuropharmacological research. Neurobiology (Bp) 6 (1998) 473-475
36. Nemeth J., Oroszi G., Than M., Helyes Z.S., Pinter E., Farkas B., and Szolcsanyi J. Substance P radioimmunoassay for quantitative characterization of sensory neurotransmitter release. Neurobiology (Bp) 7 (1999) 437-444
37. Nemeth J., Than M., Sari R., Peitl B., Oroszi G., Farkas B., Szolcsanyi J., and Szilvassy Z. Impairment of neurogenic inflammatory and anti-inflammatory responses in diabetic rats. Eur J Pharmacol 386 (1999) 83-88
38. Nemeth J., Jakab B., Reglodi D., Lubics A., Jozsa R., Hollosy T., Tamas A., Lengvari I., Gorcs T., and Szolcsanyi J. Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay. Regul Pept 109 (2002) 3-7
39. Schoenfeld L.K., Souder J.A., and Hardwick J.C. Pituitary adenylate cyclase-activating polypeptide innervation of the mudpuppy cardiac ganglion. Brain Res 882 (2000) 180-190
40. Shigyo M., Aizawa H., Inoue H., Matsumoto K., Takata S., and Hara N. Pituitary adenylate cyclase activating peptide regulates neurally mediated airway responses. Eur Respir J 12 (1998) 64-70
41. Skakkebaek M., Hannibal J., and Fahrenkrug J. Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland. Cell Tissue Res 298 (1999) 153-159
42. Somogyvari-Vigh A., and Reglodi D. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10 (2004) 2861-2889
43. Steinhoff M., McGregor G.P., Radleff-Schlimme A., Steinhoff A., Jarry H., and Schmidt W.E. Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis. Regul Pept 80 (1999) 49-55
44. Strange-Vognsen H.H., Arnbjerg J., and Hannibal J. Immunocytochemical demonstration of pituitary adenylate cyclase activating polypeptide (PACAP) in the porcine epiphyseal cartilage canals. Neuropeptides 31 (1997) 137-141
45. Szolcsanyi J. Antidromic vasodilatation and neurogenic inflammation. Agents Actions 23 (1988) 4-11
46. Szolcsanyi J. Neurogenic inflammation: reevaluation of axon reflex theory. In: Geppetti P., and Holzer P. (Eds). Neurogenic inflammation (1996), CRC Press, Boca Raton, FL 33-42
47. Szolcsanyi J., Helyes Z., Oroszi G., Nemeth J., and Pinter E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 123 (1998) 936-942
48. Szolcsanyi J., Pinter E., Helyes Z., Oroszi G., and Nemeth J. Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol 125 (1998) 916-922
49. Tornoe K., Hannibal J., Georg B., Schmidt P.T., Hilsted L., Fahrenkrug J., and Holst J.J. PACAP 1-38 as neurotransmitter in the porcine antrum. Regul Pept 101 (2001) 109-121
50. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52 (2000) 269-324
51. Wang Z.Y., Alm P., and Hakanson R. Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye. Neuroscience 69 (1995) 297-308
52. Wang Z.Y., Waldeck K., Grundemar L., and Hakanson R. Ocular inflammation induced by electroconvulsive treatment: contribution of nitric oxide and neuropeptides mobilized from C-fibres. Br J Pharmacol 120 (1997) 1491-1496
53. Warren J.B., Wilson A.J., Loi R.K., and Coughlan M.L. Opposing roles of cyclic AMP in the vascular control of edema formation. FASEB J 7 (1993) 1394-1400
54. Zhang Y.Z., Hannibal J., Zhao Q., Moller K., Danielsen N., Fahrenkrug J., and Sundler F. Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: up-regulation after peripheral nerve injury. Neuroscience 74 (1996) 1099-1110
55. Zhang Y., Malmberg A.B., Yaksh T.L., Sjolund B., Sundler F., and Hakanson R. Capsaicin-evoked release of pituitary adenylate cyclase activating peptide (PACAP) and calcitonin gene-related peptide (CGRP) from rat spinal cord in vivo. Regul Pept 69 (1997) 83-87
56. Zhou C.J., Shioda S., Yada T., Inagaki N., Pleasure S.J., and Kikuyama S. PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. Curr Protein Pept Sci 3 (2002) 423-439